Page 2 of 6 · 139 questions tagged lipids.
Setup, so nobody has to ask: eGFR · six weeks · tirzepatide. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the…
Stated plainly: LDL-C · cagrilintide. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My background is…
For reference: cystatin C · creatinine · a GLP-1 receptor agonist. I am trying to choose between two options that are usually discussed as though only one exists. I…
The specifics, since they change the answer: triglycerides · LDL-C · cagrilintide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I…
I am reading the trial table rather than the press release, which is why the numbers differ. I can parse the result. I am less sure what it licenses me to conclude. I…
What I am working with: magnesium · twelve weeks · orforglipron. I have two candidate explanations and no way to distinguish them. The same procedure has worked…
What I am working with: GGT · four weeks · dulaglutide. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to…
What I am working with: lipase · two weeks · survodutide. This is not behaving the way I expected and I want to understand the discrepancy before I act on it. I have…
For reference: ApoB · retatrutide. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…
I have three data points across nine months, which I hope is enough to see a trend. I want to understand what this actually establishes, as opposed to what it is…
Stated plainly: triglycerides · ecnoglutide. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have tried to…
For reference: GGT · albumin-to-creatinine ratio · dulaglutide. I would like the axes of comparison first and the recommendation second. I have tried the first option…
I am reading the trial table rather than the press release, which is why the numbers differ. I want to understand what this actually establishes, as opposed to what…
Twelve weeks in, losing roughly 1.1 kg a week, and my fasting LDL-C has gone from 2.7 to 3.3 mmol/L. Total cholesterol up from 4.6 to 5.2. Triglycerides down from 1.9…
I am reading the trial table rather than the press release, which is why the numbers differ. This is presented as though it settles something, and I am not convinced…
Details up front: triglycerides · survodutide. I am at the decision point and I would rather think it through than improvise. I would rather spend money on…
For reference: cystatin C · three weeks · a GLP-1 receptor agonist. An unexpected observation, and I would like a differential rather than reassurance. The conditions…
What I am working with: creatinine · cystatin C · ecnoglutide. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I…
The specifics, since they change the answer: ApoB · retatrutide. This is a planning question. I know what my options are; I do not know how to weigh them. What I want…
The case in front of me: cystatin C · creatinine · cagrilintide. I am trying to choose between two options that are usually discussed as though only one exists. I am…
What I have: ALT · AST · ecnoglutide. Both of these get recommended confidently by different people, which suggests neither is obviously right. My constraints are…
I have the full paper rather than the abstract, and the supplementary appendix. I have the document in front of me and I can read the numbers. What I cannot do is…
The particulars: LDL-C · mazdutide. I am trying to build something sustainable rather than something thorough that I will abandon. I have already decided the broad…
Setup, so nobody has to ask: triglycerides · semaglutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with…